Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice

Japanese Journal of Pharmacology

Volumn 73, Issue 3, 1997, Pages 251-254

  Mori, Tomohisa ^a   Murase, Kenshi ^a   Tanaka, Jiro ^a   Ichimaru, Yasuyuki ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

D1 receptor agonist; D3 receptor agonist; Motor activity

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; KAPPA OPIATE RECEPTOR AGONIST; POSTSYNAPTIC RECEPTOR; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H (1)BENZOPYRANO(4,3 B) 1,4 OXAZIN 9 OL; 3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-(1)BENZOPYRANO(4,3-B)-1,4-OXAZIN-9-OL; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BENZAZEPINE DERIVATIVE; BENZOPYRAN DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, MOUSE; KAPPA OPIATE RECEPTOR; OXAZINE DERIVATIVE; SK&F 81297; TETRALIN DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION;

ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; BENZOPYRANS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; MOTOR ACTIVITY; OXAZINES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, KAPPA; TETRAHYDRONAPHTHALENES;

EID: 0030611328     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.251     Document Type: Article

References (15)

1. Sibley DR and Monsma FJ Jr: Molecular biology of dopamine receptors. Trends Pharmacol Sci 13, 61-69 (1992)
2. 1 receptor agonists in mice and rats: relation between behavioral effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213, 259-267 (1992)
3. 2 dopamne receptors in the modulation of the reinforcing effect of brain stimulation. Behav Neurosci 107, 161-165 (1993)
4. 2 receptors and spinal cord excitation in mice. Eur J Pharmacol 184, 207-212 (1990)
5. Di Chiara G, Porceddu ML, Vargiu L, Argiolas A and Gessa GL: Evidence for dopamine receptor in the mouse brain mediating sedation. Nature 264, 564-567 (1976)
6. 3 receptors. Eur J Pharmacol 263, 235-243 (1994)
7. 3 agonist PD128907. J Pharmacol Exp Ther 275, 1355-1366 (1995)
8. Funada M, Suzuki T, Shiozaki Y, Narita M, Masukawa Y, Misawa M and Nagase H: Blockade of morphine reward through the activation of κ-opioid receptors in mice. Neuropharmacology 32, 1315-1323 (1993)
9. Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M and Nagase H: Effects of κ-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn J Pharmacol 62, 15-24 (1993)
10. 3) as a target for neuroleptics. Nature 347, 146-151 (1990)
11. Mallet PE and Beninger RJ: 7-OH-DPAT produces place conditioning in rats. Eur J Pharmacol 261, R5-R6 (1994)
12. 3-receptor agonist (±)7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187, 45-48 (1995)
13. Caine SB and Koob GF: Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6, 333-347 (1995)
14. 3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology (Berlin) 122, 351-357 (1995)
15. 3 receptors. Eur J Pharmacol 277, 151-158 (1995)